(LIFCO-B) Lifco (publ) - ST

Sector: Industrials | Industry: Conglomerates | Exchange: ST (Sweden) | Market Cap: 139.172m SEK | Total Return: -18.3% in 12m

Dental Supplies, Demolition Robots, Excavator Attachments, Vehicle Interiors
Total Rating 34
Safety 79
Buy Signal -0.34
Conglomerates
Industry Rotation: +1.4
Market Cap: 14.5B
Avg Turnover: 141M
Risk 3d forecast
Volatility24.7%
VaR 5th Pctl4.21%
VaR vs Median3.68%
Reward TTM
Sharpe Ratio-0.82
Rel. Str. IBD22.1
Rel. Str. Peer Group15
Character TTM
Beta0.685
Beta Downside0.550
Hurst Exponent0.571
Drawdowns 3y
Max DD32.20%
CAGR/Max DD0.37
CAGR/Mean DD1.17
EPS (Earnings per Share) EPS (Earnings per Share) of LIFCO-B over the last years for every Quarter: "2021-06": 1.43, "2021-09": 1.13, "2021-12": 3.1, "2022-03": 1.85, "2022-06": 1.66, "2022-09": 1.46, "2022-12": 1.65, "2023-03": 1.72, "2023-06": 1.91, "2023-09": 1.63, "2023-12": 2, "2024-03": 1.52, "2024-06": 2, "2024-09": 1.64, "2024-12": 2.16, "2025-03": 1.84, "2025-06": 1.93, "2025-09": 2, "2025-12": 2.29, "2026-03": 1.99,
EPS CAGR: 6.86%
EPS Trend: 95.9%
Last SUE: -1.08
Qual. Beats: -1
Revenue Revenue of LIFCO-B over the last years for every Quarter: 2021-06: 4501, 2021-09: 4158, 2021-12: 4952, 2022-03: 5022, 2022-06: 5508, 2022-09: 5020, 2022-12: 6002, 2023-03: 5959, 2023-06: 6206, 2023-09: 5850, 2023-12: 6439, 2024-03: 6006, 2024-06: 6725, 2024-09: 6282, 2024-12: 7125, 2025-03: 6933, 2025-06: 6943, 2025-09: 6842, 2025-12: 7534, 2026-03: 7186,
Rev. CAGR: 7.91%
Rev. Trend: 99.3%
Last SUE: -0.74
Qual. Beats: 0

Warnings

No concerns identified

Tailwinds

No distinct edge detected

Description: LIFCO-B Lifco (publ)

Lifco AB is a Swedish industrial conglomerate that operates through three primary segments: Dental, Demolition & Tools, and Systems Solutions. The company functions as a decentralized investment firm, acquiring and managing a diverse portfolio of niche market leaders across Europe, North America, and Asia. Its product range spans from dental laboratory consumables and medical software to demolition robotics and infrastructure components for the telecommunications and energy sectors.

The company utilizes a serial acquisition business model, focusing on small-to-medium enterprises (SMEs) with high profitability and sustainable market positions. This strategy allows Lifco to minimize cyclical risk by diversifying across unrelated industrial sectors, such as forestry, nuclear power, and dental healthcare. As a subsidiary of Carl Bennet AB, the firm emphasizes long-term ownership and operational autonomy for its subsidiaries rather than aggressive integration.

Headlines to Watch Out For
  • M&A execution and capital allocation drive long-term earnings growth
  • Demolition and Tools segment margins depend on global construction activity
  • Dental segment provides stable cash flows through consumable distribution
  • Systems Solutions revenue fluctuates with European industrial and infrastructure spending
Piotroski VR-10 (Strict) 4.0
Net Income: 3.70b TTM > 0 and > 6% of Revenue
FCF/TA: 0.11 > 0.02 and ΔFCF/TA -0.16 > 1.0
NWC/Revenue: 1.84% < 20% (prev -2.88%; Δ 4.72% < -1%)
CFO/TA 0.12 > 3% & CFO 5.10b > Net Income 3.70b
Net Debt (10.5b) to EBITDA (7.12b): 1.47 < 3
Current Ratio: 1.05 > 1.5 & < 3
Outstanding Shares: last quarter (454.0m) vs 12m ago 0.17% < -2%
Gross Margin: 43.89% > 18% (prev 44.16%; Δ -0.26% > 0.5%)
Asset Turnover: 71.14% > 50% (prev 71.69%; Δ -0.55% > 0%)
Interest Coverage Ratio: 13.38 > 6 (EBIT TTM 5.23b / Interest Expense TTM 391.0m)
Altman Z'' 3.40
A: 0.01 (Total Current Assets 11.1b - Total Current Liabilities 10.6b) / Total Assets 42.4b
B: 0.45 (Retained Earnings 19.0b / Total Assets 42.4b)
C: 0.13 (EBIT TTM 5.23b / Avg Total Assets 40.1b)
D: 0.93 (Book Value of Equity 20.4b / Total Liabilities 21.8b)
Altman-Z'' = 3.40 = A
Beneish M -2.95
DSRI: 1.04 (Receivables 5.13b/4.68b, Revenue 28.5b/27.1b)
GMI: 1.01 (GM 44.16% / 43.89%)
AQI: 1.01 (AQ_t 0.66 / AQ_t-1 0.65)
SGI: 1.05 (Revenue 28.5b / 27.1b)
TATA: -0.03 (NI 3.70b - CFO 5.10b) / TA 42.4b)
Beneish M = -2.95 (Cap -4..+1) = A
What is the price of LIFCO-B shares?

As of June 22, 2026, the stock is trading at SEK 307.00 with a total of 820,800 shares traded. Over the past week, the price has changed by +1.39%, over one month by +4.42%, over three months by +11.79% and over the past year by -18.32%.

Current recommended Stop Loss: 287.60 (which is 6.3% or 2.6 ATR below the current price).

Is LIFCO-B a buy, sell or hold?

Lifco (publ) has no consensus analysts rating.

Lifco (publ) (LIFCO-B) - Fundamental Data Overview as of 18 June 2026
Market Cap USD = 14.5b (139b SEK * 0.1042 SEK.USD)
P/E Trailing = 37.6876
P/E Forward = 35.7143
P/S = 4.8825
P/B = 6.8875
Revenue TTM = 28.5b SEK
EBIT TTM = 5.23b SEK
EBITDA TTM = 7.12b SEK
Long Term Debt = 5.38b SEK (from longTermDebt, last fiscal year)
Short Term Debt = 5.03b SEK (from shortTermDebt, last quarter)
Debt = 11.9b SEK (from shortLongTermDebtTotal, last quarter) + Leases 1.32b
Net Debt = 10.5b SEK (calculated: Debt 11.9b - CCE 1.42b)
Enterprise Value = 150b SEK (139b + Debt 11.9b - CCE 1.42b)
Interest Coverage Ratio = 13.38 (Ebit TTM 5.23b / Interest Expense TTM 391.0m)
EV/FCF = 32.15x (Enterprise Value 150b / FCF TTM 4.66b)
FCF Yield = 3.11% (FCF TTM 4.66b / Enterprise Value 150b)
FCF Margin = 16.33% (FCF TTM 4.66b / Revenue TTM 28.5b)
Net Margin = 12.97% (Net Income TTM 3.70b / Revenue TTM 28.5b)
Gross Margin = 43.89% ((Revenue TTM 28.5b - Cost of Revenue TTM 16.0b) / Revenue TTM)
Gross Margin QoQ = 44.41% (prev 43.74%)
Tobins Q-Ratio = 3.53 (Enterprise Value 150b / Total Assets 42.4b)
Interest Expense / Debt = 3.28% (Interest Expense 391.0m / Debt 11.9b)
Taxrate = 22.91% (1.11b / 4.84b)
NOPAT = 4.03b (EBIT 5.23b * (1 - 22.91%))
Current Ratio = 1.05 (Total Current Assets 11.1b / Total Current Liabilities 10.6b)
Debt / Equity = 0.59 (Debt 11.9b / totalStockholderEquity, last quarter 20.4b)
Debt / EBITDA = 1.47 (Net Debt 10.5b / EBITDA 7.12b)
Debt / FCF = 2.26 (Net Debt 10.5b / FCF TTM 4.66b)
Total Stockholder Equity = 19.0b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.23% (Net Income 3.70b / Total Assets 42.4b)
RoE = 19.44% (Net Income TTM 3.70b / Total Stockholder Equity 19.0b)
RoCE = 21.44% (EBIT 5.23b / Capital Employed (Equity 19.0b + L.T.Debt 5.38b))
RoIC = 11.40% (NOPAT 4.03b / Invested Capital 35.4b)
WACC = 7.93% (E(139b)/V(151b) * Re(8.39%) + D(11.9b)/V(151b) * Rd(3.28%) * (1-Tc(0.23)))
Discount Rate = 8.39% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 13.80 | Cagr: -0.02%
[DCF] Terminal Value 76.74% ; FCFF base≈4.48b ; Y1≈4.89b ; Y5≈6.14b
[DCF] Fair Price = 196.6 (EV 93.8b - Net Debt 10.5b = Equity 83.3b / Shares 423.8m; r=8.35% [WACC [floored]]; 5y FCF grow 10.67% → 2.50% )
EPS Correlation: 95.88 | EPS CAGR: 6.86% | SUE: -1.08 | # QB: -1
Revenue Correlation: 99.28 | Revenue CAGR: 7.91% | SUE: -0.74 | # QB: 0
EPS current Quarter (2026-06-30): EPS=2.51 | Chg30d=+11.20% | Revisions=-20% | Analysts=2
EPS next Quarter (2026-09-30): EPS=2.34 | Chg30d=+11.19% | Revisions=-20% | Analysts=2
EPS current Year (2026-12-31): EPS=10.02 | Chg30d=+0.39% | Revisions=+14% | GrowthEPS=+24.1% | GrowthRev=+6.9%
EPS next Year (2027-12-31): EPS=10.89 | Chg30d=-0.78% | Revisions=+43% | GrowthEPS=+8.7% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: +43%